Jochelson Philip 4
4 · Somaxon Pharmaceuticals, Inc. · Filed Mar 23, 2007
Insider Transaction Report
Form 4
Jochelson Philip
Senior VP and Chief Medical
Transactions
- Exercise/Conversion
Common Stock
2007-03-21$2.40/sh+2,170$5,208→ 2,170 total - Sale
Common Stock
2007-03-21$13.01/sh−2,170$28,232→ 0 total - Exercise/Conversion
Stock Option (right to buy)
2007-03-21−2,170→ 42,266 totalExercise: $2.40Exp: 2015-04-02→ Common Stock (2,170 underlying)
Footnotes (3)
- [F1]This sale was effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 9/11/2006, as amended to date.
- [F2]14,054 shares of common stock subject to the option are vested and exercisable as of 3/23/07 and approximately 1,128 vest and become exercisable on the first day of each month until April 1, 2009.
- [F3]Not applicable.